Federal Register Notice: FDA will co-sponsor with PhRMA and the American Association for the Study of Liver Diseases a public conference 3/23-24 entitled “Drug-Induced Liver Injury: Are We Ready to Look?” It will consider the effect of the recommendations in the 7/09 guidance, Drug-Induced Liver Injury: Premarketing Clinical Evaluation and seek suggestions for future revision. The conference will be held 3/23, from 8 a.m. to 6 p.m. and 3/24, from 8 a.m. until 3:30 p.m. at the National Labor College, 10000 New Hampshire Ave., Silver Spring, MD. Contact Lana L. Pauls, (301) 796-0518. To view this notice, click here.